Verigene test sales fuel Q2 revenue growth for Nanosphere

08/7/2013 | GenomeWeb Daily News (free registration)

Northbrook, Ill.-based Nanosphere posted revenues of $1.9 million during the second quarter, up from $1.3 million in the same period last year. The molecular diagnostics company attributes this revenue growth to sales generated from its Verigene Gram-Positive Blood Culture Test.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA